Home    About NDEI   Site Map   FAQ   Contact Us   Feedback   
       Advanced Search    
Home
Slide Library
Literature Alerts
On Demand Activities
Case Studies
Newsletters
Live Events
Treatment Guidelines
Patient Education
Clinical Trials
Product Indications
Calendar Of Events
Glossary
Other Resources
CME Opportunities


Your Online Resource for Diabetes Treatment
Home > Literature Alerts > Archived by Journal > Diabetic Medicine

Diabetic Medicine


Add to Google
Liraglutide, a once-daily human GLP-1 analogue, improves pancreatic B-cell function and arginine-stimulated insulin secretion during hyperglycaemia in patients with Type 2 diabetes mellitus
Vilsbøll T, Brock B, Perrild H, et al
Diabet Med. 2008;25(2):152-156
Rosiglitazone RECORD study: glucose control outcomes at 18 months
Home PD, Jones NP, Pocock SJ, et al
Diabet Med. 2007;24:626–634
Association of diabetes-related emotional distress with diabetes treatment in primary care patients with Type 2 diabetes
Delahanty LM, Grant RW, Wittenberg E, et al
Diabet Med. 2007;24:48-54
A randomized trial of adding insulin glargine vs. avoidance of insulin in people with Type 2 diabetes on either no oral glucose-lowering agents or submaximal doses of metformin and/or sulphonylureas. The Canadian INSIGHT Study.
Gerstein HC, Yale JF, Harris SB, et al
Diabet Med. 2006;23:736-742
Hormone replacement therapy is associated with increased C-reactive protein in women with Type 2 diabetes in the Diabetes Heart Study
Bowden DW, Lohman K, Hsu FC, et al
Diabet Med. 2006;23:763-767
Pregnancy in women with Type 2 diabetes: who takes metformin and what is the outcome?
Hughes RC, Rowan JA
Diabet Med. 2006;23:318-322
Metformin use and diabetic pregnancy-has its time come?
Hawthorne G
Diabet Med. 2006;23:223-227
Pathophysiology of ketoacidosis in Type 2 diabetes mellitus
Linfoot P, Bergstrom C, Ipp E
Diabet Med. 2005;22:1414-1419
Long-term effects of pioglitazone and metformin on insulin sensitivity in patients with Type 2 diabetes mellitus
Roden M, Laakso M, Johns D, et al
Diabet Med. 2005;22:1101-1106
Increases in body mass index, even within non-obese levels, raise the risk for Type 2 diabetes mellitus: a follow-up study in a Japanese population
Nagaya T, Yoshida H, Takahashi H, Kawai M
Diabet Med. 2005;22:1107-1111
A long-term comparison of pioglitazone and gliclazide in patients with Type 2 diabetes mellitus: a randomized, double-blind, parallel-group comparison trial
Charbonnel BH, Matthews DR, Schernthaner G, Hanefeld M, Brunetti P
Diabet Med. 2005;22:399-405
 

Clinical Bridges, Secaucus, NJ
Clinical Bridges is a division of KnowledgePoint360 Group, LLC.
Copyright © 2009 Clinical Bridges. All rights reserved.
National Diabetes Education Initiative, Clinical Bridges, and
KnowledgePoint360 are trademarks of KnowledgePoint360 Group, LLC.
Disclaimer Statement - Privacy Statement